miR-128 inhibits telomerase activity by targeting TERT mRNA
H. Guzman, K. Sanders, A. Idica, A. Bochnakian, D. Jury, I. Daugaard, D. G. Zisoulis, I. Pedersen
This paper identifies miR-128 as a novel telomerase inhibitor that directly targets TERT mRNA, reducing its expression in cancer cell lines.
bioRxiv · Oct 6, 2017Cancer Biology